TELA Bio, Inc. ( TELA) - Key Metrics
TELA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.34 | -$0.20 | -$0.16 | -$0.16 |
| 2026Q1 | $0.33 | -$0.21 | -$0.20 | -$0.20 |
| 2025Q4 | $0.40 | -$0.17 | -$0.09 | -$0.10 |
| 2025Q3 | $0.46 | -$0.19 | -$0.13 | -$0.13 |
| 2025Q2 | $0.45 | -$0.22 | -$0.17 | -$0.18 |
TELA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.94 |
| 2026Q1 | 0% | -0.74 |
| 2025Q4 | 0% | -1.74 |
| 2025Q3 | 0% | -1.96 |
| 2025Q2 | 0% | -2.20 |
TELA
Price: $1.08
52 week price:
Earnings Per Share: -0.77 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 32300
Market Capitalization: 51.0 million